489 related articles for article (PubMed ID: 34111453)
1. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
[TBL] [Abstract][Full Text] [Related]
2. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza.
Cambier S; Metzemaekers M; de Carvalho AC; Nooyens A; Jacobs C; Vanderbeke L; Malengier-Devlies B; Gouwy M; Heylen E; Meersseman P; Hermans G; Wauters E; Wilmer A; ; Schols D; Matthys P; Opdenakker G; Marques RE; Wauters J; Vandooren J; Proost P
JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34793331
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
Shaath H; Vishnubalaji R; Elkord E; Alajez NM
Cells; 2020 Oct; 9(11):. PubMed ID: 33138195
[TBL] [Abstract][Full Text] [Related]
5. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
Park JH; Lee HK
Front Immunol; 2020; 11():2145. PubMed ID: 32983174
[TBL] [Abstract][Full Text] [Related]
6. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
Reynolds D; Vazquez Guillamet C; Day A; Borcherding N; Vazquez Guillamet R; Choreño-Parra JA; House SL; O'Halloran JA; Zúñiga J; Ellebedy AH; Byers DE; Mudd PA
J Immunol; 2021 Sep; 207(5):1229-1238. PubMed ID: 34348975
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Hyperinflammation: What about Neutrophils?
Didangelos A
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581077
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.
Zhang F; Mears JR; Shakib L; Beynor JI; Shanaj S; Korsunsky I; Nathan A; ; Donlin LT; Raychaudhuri S
Genome Med; 2021 Apr; 13(1):64. PubMed ID: 33879239
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes.
Gelarden I; Nguyen J; Gao J; Chen Q; Morales-Nebreda L; Wunderink R; Li L; Chmiel JS; Hrisinko M; Marszalek L; Momnani S; Patel P; Sumugod R; Chao Q; Jennings LJ; Zembower TR; Ji P; Chen YH
Hum Pathol; 2021 Jul; 113():92-103. PubMed ID: 33905777
[TBL] [Abstract][Full Text] [Related]
11. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
[TBL] [Abstract][Full Text] [Related]
12. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
15. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
Front Immunol; 2021; 12():738093. PubMed ID: 34777349
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
17. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
Front Immunol; 2021; 12():626235. PubMed ID: 33584733
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
Kowal-Bielecka O; Kowal K; Distler O; Rojewska J; Bodzenta-Lukaszyk A; Michel BA; Gay RE; Gay S; Sierakowski S
Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329
[TBL] [Abstract][Full Text] [Related]
20. Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.
Croci GA; Vaira V; Trabattoni D; Biasin M; Valenti L; Baselli G; Barberis M; Guerini Rocco E; Gregato G; Scandroglio M; Fominskiy E; Palleschi A; Rosso L; Nosotti M; Clerici M; Ferrero S
Cells; 2021 Mar; 10(3):. PubMed ID: 33801959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
